AAAAAA

   
Results: 1-9 |
Results: 9
T(2-5) POSITIVE LYMPHOMA WITH PERIPHERAL-BLOOD INVOLVEMENT
Authors: CHHANABHAI M BRITTEN C KLASA R GASCOYNE RD
Citation: M. Chhanabhai et al., T(2-5) POSITIVE LYMPHOMA WITH PERIPHERAL-BLOOD INVOLVEMENT, Leukemia & lymphoma, 28(3-4), 1998, pp. 415-422
A PHASE-I AND PHARMACOLOGICAL STUDY OF THE ORAL MATRIX METALLOPROTEINASE INHIBITOR, BAY 12-9566, IN COMBINATION WITH PACLITAXEL AND CARBOPLATIN
Authors: ECKHARDT SG RIZZO J BRITTEN C SIU L HUMPHREY R SMETZER L SORENSEN M SUNDARESAN P VONHOFF DD ROWINSKY EK
Citation: Sg. Eckhardt et al., A PHASE-I AND PHARMACOLOGICAL STUDY OF THE ORAL MATRIX METALLOPROTEINASE INHIBITOR, BAY 12-9566, IN COMBINATION WITH PACLITAXEL AND CARBOPLATIN, Annals of oncology, 9, 1998, pp. 614-614
PHASE-I AND PHARMACOKINETIC (PK) STUDY OF THE GLYCINAMIDE RIBONUCLEOTIDE FORMYLTRANSFERASE INHIBITOR LY309887 AS A BOLUS EVERY 3 WEEKS WITHFOLIC-ACID
Authors: AYLESWORTH C BAKER SD STEPHENSON J BRITTEN C MONROE P WALLING J JOHNSON R VONHOFF D ROWINSKY E
Citation: C. Aylesworth et al., PHASE-I AND PHARMACOKINETIC (PK) STUDY OF THE GLYCINAMIDE RIBONUCLEOTIDE FORMYLTRANSFERASE INHIBITOR LY309887 AS A BOLUS EVERY 3 WEEKS WITHFOLIC-ACID, Annals of oncology, 9, 1998, pp. 610-610
A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF ZD9331, A NOVEL LONG-ACTING THYMIDYLATE SYNTHETASE (TS) INHIBITOR, ON A SINGLE DOSING EVERY 3 WEEKS SCHEDULE
Authors: DIAB S BRITTEN C SMITH R ECKHARDT SG BAKER S HAMMOND L SIU L SHARMA S HIDALGO M AYLESWORTH C YOUNG R WONG L RAZVILLAS B KRAYNAK M DOUGLASS E VONHOFF D ROWINSKY E
Citation: S. Diab et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF ZD9331, A NOVEL LONG-ACTING THYMIDYLATE SYNTHETASE (TS) INHIBITOR, ON A SINGLE DOSING EVERY 3 WEEKS SCHEDULE, Annals of oncology, 9, 1998, pp. 611-611
A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF PN401 AS A RESCUE AGENT FOR ESCALATING DOSES OF 5-FLUOROURACIL (5-FU) IN PATIENTS WITH CANCER
Authors: HIDALGO M VILLALONACALERO MA BRITTEN C SIU L DRENGLER R HAMMOND L DIAB S CAMPBELL E LOUIE A ONEIL J VONHOFF D ROWINSKY E
Citation: M. Hidalgo et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF PN401 AS A RESCUE AGENT FOR ESCALATING DOSES OF 5-FLUOROURACIL (5-FU) IN PATIENTS WITH CANCER, Annals of oncology, 9, 1998, pp. 625-625
COMBINED LOCAL AND SYSTEMIC THERAPY FOR SMALL-CELL CARCINOMA OF THE ENDOMETRIUM
Authors: BRITTEN C HOSKINS P SWENERTON K PIKE J WONG F
Citation: C. Britten et al., COMBINED LOCAL AND SYSTEMIC THERAPY FOR SMALL-CELL CARCINOMA OF THE ENDOMETRIUM, International journal of gynecological cancer, 7(6), 1997, pp. 480-485
AN IMPROVED METHOD FOR THE SYNTHESIS OF GDP-HEXANOLAMINE DERIVATIVES,KEY REAGENTS FOR THE PURIFICATION AND CHARACTERIZATION OF CARBOHYDRATE PROCESSING ENZYMES
Authors: BAMFORD M BRITTEN C DRAEGER E GORE P HOLMES DS
Citation: M. Bamford et al., AN IMPROVED METHOD FOR THE SYNTHESIS OF GDP-HEXANOLAMINE DERIVATIVES,KEY REAGENTS FOR THE PURIFICATION AND CHARACTERIZATION OF CARBOHYDRATE PROCESSING ENZYMES, Journal of carbohydrate chemistry, 15(6), 1996, pp. 727-737
INCEST FANTASIES AND SELF-DESTRUCTIVE ACTS - JUNGIAN AND POST-JUNGIANPSYCHOTHERAPY IN ADOLESCENCE - SIDOLI,M, BOVENSIEPEN,G
Authors: BRITTEN C
Citation: C. Britten, INCEST FANTASIES AND SELF-DESTRUCTIVE ACTS - JUNGIAN AND POST-JUNGIANPSYCHOTHERAPY IN ADOLESCENCE - SIDOLI,M, BOVENSIEPEN,G, Journal of analytical psychology, 41(3), 1996, pp. 441-442
CHEMICAL MODIFICATION OF ALPHA(1-3) FUCOSYL-TRANSFERASE DEFINES RESIDUES OF CATALYTIC IMPORTANCE
Authors: BRITTEN C HOOD C BIRD M
Citation: C. Britten et al., CHEMICAL MODIFICATION OF ALPHA(1-3) FUCOSYL-TRANSFERASE DEFINES RESIDUES OF CATALYTIC IMPORTANCE, Biochemical Society transactions, 23(2), 1995, pp. 166-166
Risultati: 1-9 |